冠心丹参方及其有效成分治疗冠心病的研究进展
2016-11-19汤世民邢小燕邓雪红赵娜娜李光杨
汤世民+邢小燕+邓雪红+赵娜娜+李光+杨锐创+孙桂波+孙晓波
[摘要]冠心病是临床常见的心血管疾病之一,近年来在我国的发病率和死亡率呈上升趋势,引起了人们的广泛关注。中医药在冠心病的治疗上有较好的效果,已被诸多研究证实。冠心丹参方是临床治疗冠心病的常用中药复方,由丹参、三七和降香油组成,具有活血化瘀、理气止痛的功效。该文对冠心丹参方及其有效成分治疗冠心病的药理作用及作用机制进行了综述,以期为冠心丹参方的基础研究和临床应用提供参考。
[关键词]冠心丹参方; 冠心病; 药理作用; 作用机制
[Abstract]Coronary artery heart disease (CHD) is one of the common cardiovascular diseases in clinical. The morbidity and mortality of CHD recently continue increasing in our country, which has aroused wide attention. Many studies confirm that traditional Chinese medicine has better therapeutic effect on CHD. Guanxin Danshen formula, widely used in the treatment of CHD, consists of Salviae Miltiorrhizae Radix et Rhizoma, Notoginseng Radix et Rhizoma and volatile oil from Dalbergiae Odoriferae Lignum, and has the efficacy in promoting blood circulation to resolve stasis, regulating the circulation of Qi and alleviating pain. This review summarized the pharmacologic effects and mechanism of Guanxin Danshen formula and its effective components in the treatment of CHD to provide reference for its fundamental research and clinical application.
[Key words]Guanxin Danshen formula; coronary artery heart disease; pharmacological effects; mechanism
doi:10.4268/cjcmm20162004
冠状动脉性心脏病(coronary artery heart disease, CHD)简称冠心病,是一种常见的心血管疾病,是指因冠状动脉狭窄、供血不足而引起的心肌机能障碍和(或)器质性病变,故又称缺血性心脏病(IHD)。CHD是多种冠状动脉病的结果,但冠状动脉粥样硬化(atherosclerosis)占冠状动脉性心脏病的绝大多数。因此,习惯上把CHD视为冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease)。根据其临床症状,冠心病可分为5型:心绞痛型、心肌梗塞型、无症状性心肌缺血型、心力衰竭和心律失常型、猝死型。《中国心血管病报告2015》数据显示,我国冠心病的患病率和死亡率仍处于上升阶段[1],严重威胁人们的生命健康。
冠心病属中医“胸痹”、“真心痛”范畴,其病因病机多认为是本虚标实,标实以血瘀、痰浊、气滞、寒凝为主,本虚以气虚、阴虚、阳虚为主,复合证型以气虚痰瘀型和气虚血瘀型为主,针对不同的证型应采取不同的辨证论治[2]。……
